Elegen Corp.
Menlo Park, CA
- UEI
- TM9HBLXBWML6
- CAGE
- 7XQ63
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 3565 Haven Ave #3, Menlo Park, CA 94025, USA
- Website
- elegenbio.com
- Founded
- 2017
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Novel microfluidic platform for versatile, fast, low-cost DNA synthesis and assembly | National Human Genome Research Institute (NIH) | $3,579,763 |
Quick answers
Is Elegen Corp. registered in SAM.gov?
Yes. Elegen Corp.'s SAM.gov registration is active through August 28, 2027.
What is Elegen Corp.'s most recent federal award?
Elegen Corp.'s most recent federal grant award is Novel microfluidic platform for versatile, fast, low-cost DNA synthesis and assembly (R44HG011433), from National Human Genome Research Institute (NIH), on September 23, 2020.
On GovTribe
See Elegen Corp.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors